Table 4.
The SAEs include but are not limited to | |
Major bleeding | |
Bleeding requires transfusion for > 2 units | |
Severe arrhythmias | |
Type II second-degree AVB or third-degree AVB | |
Sustained ventricular tachycardia (> 30 s) | |
Ventricular fibrillation | |
Ventilator associated pneumonia, which needs to meet all the criteria below: | |
At least 48 h after endotracheal intubation | |
Chest X-ray showing sustained or worsening shadowing (infiltrates or consolidations) | |
Signs of pulmonary consolidation and/or crackles on auscultation, at least meet one of the following criteria: | |
a) White blood cell count > 10 × 109/L or < 4 × 109/L | |
b) Temperature > 37.5 °C, purulent secretions | |
c) Positive cultures obtained directly from bronchial secretions | |
Bloodstream infection | |
Positive cultures obtained from the peripheral blood | |
SSI | |
Purulent drainage in the operated region with pain or tenderness, localized swelling, redness, and heat or fever, requiring operation, including superficial incisional wound SSI, deep incisional wound SSI, and organ/space SSI | |
Limb ischemia from any cause | |
Physical examination demonstrating pain, pallor, pulseless, cold, and motor or sensor deficit | |
Requiring decannulation of ECMO catheter or surgical intervention | |
Stroke | |
New onset abnormal neurological signs and symptoms last for at least 24 h with radiographic evidence | |
Any other severe adverse events determined by the physicians |
AVB atrioventricular block, ECMO extracorporeal membrane oxygenation, SAE serious adverse events, SSI surgical site infection